Assay Kits, Biomarkers and Antibodies Supporting Oxidative Stress Research
€800K Grant supports Large B-cell Lymphoma Project
WITec Jubilee Celebrates 25 Years of Innovation
Helium - save it or swap it
Control Processes with Intelligent Cameras – No Previous Knowledge Req...
Leading Supplier Expands Offerings with ICP-MS Cones
Following a £4.34 million award from the UK’s Science and Technology Facilities Council (STFC), particle physicists from UCL will help to further their work examining the nature of the Higgs boson at the Large Hadron Collider (LHC) and preparing for new, higher-intensity collisions that may reveal evidence of physics beyond the so-called "Standard Model".
Group leader Professor David Waters (UCL Physics & Astronomy), said: “This support from STFC and UKRI enables the UCL High Energy Physics group to continue to lead world-class projects addressing pressing questions in collider physics, neutrino physics, precision muon physics, the search for dark matter and much else besides.”
Professor Andreas Korn (UCL Physics & Astronomy), the primary investigator, said: “We particularly appreciate the continued support for our highly skilled engineers and technicians who make our experiments a reality and enable us to do cutting-edge science. The grant also provides the background and infrastructure to develop our PhD students into the highly skilled scientists and employees of the future."
The UCL High Energy Physics Group leads a number of experiments probing the properties of the most abundant matter particle in the universe - the neutrino, which will measure the asymmetry between matter and antimatter in the neutrino sector and may cast light on the mechanism that has generated the cosmological matter-antimatter asymmetry; the group also leads UK efforts to measure the flux of the highest-energy cosmic-ray neutrinos.
UCL physicists also play a leading role in international efforts to directly detect the interaction of elusive dark-matter particles, which also may be created directly in the laboratory at the LHC and the group has begun exploring innovative quantum technologies that may open up new opportunities for ultra-precise measurements.
Work also continues on a programme of detector and accelerator R&D focused on medical applications, building on a strong, recent UCL track record in this area. For instance, a team co-led by Professor Simon Jolly (UCL Physics & Astronomy) working with the German Cancer Research Centre in Heidelberg demonstrated how a mixed particle beam could enable simultaneous cancer therapy and treatment monitoring.
Therapeutics developer Lead Pharmaceutical (Oss, Netherlands) and French medicinal chemistry and custom synthesis company Oxeltis, have been awarded an €80...
A screening tool developed in research led at the University of Strathclyde could increase the number of tests on a solid tumour sample by up to 50 times....
The Eppendorf SE Young European Investigators 2022 Award ceremony, which took place at the spectacular and dynamic EMBL Advanced Training Centre in Heidelber...
Suzhou Basecare Medical Corporation Ltd has announced that the company entered into a strategic collaboration framework agreement with Qingdao Haier Biomedic...
In This Edition Evaluation of Recovery of Basic Analytes Using a Mixed-Mode Strong Cation Exchange SPE Microplate by HPLC-MS The Benefits of SEC-MALLS in Biopharmaceutical Applications...
AACC Annual Meeting & Clinical Lab Expo
ACS National Meeting & Expo, Fall 2022
Aug 21 2022 Chicago, IL, USA & Online
International Labmate Limited Oak Court Business Centre Sandridge Park, Porters Wood St Albans Hertfordshire AL3 6PH United Kingdom
T +44 (0)1727 858 840 F +44 (0)1727 840 310 E info@labmate-online.com
Copyright © 2022 Labmate Online. All rights reserved.